These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15341939)

  • 1. New DNA binding ligands as a model of chromomycin A3.
    Imoto S; Haruta Y; Watanabe K; Sasaki S
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4855-9. PubMed ID: 15341939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of DNA recognition by anticancer antibiotics, chromomycin A(3), and mithramycin: roles of minor groove width and ligand flexibility.
    Chakrabarti S; Bhattacharyya D; Dasgupta D
    Biopolymers; 2000-2001; 56(2):85-95. PubMed ID: 11592055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interactions of the Mg2+ complexes of chromomycin A3 and mithramycin with poly(dG-dC) x poly(dC-dG) and poly(dG) x poly(dC).
    Majee S; Sen R; Guha S; Bhattacharyya D; Dasgupta D
    Biochemistry; 1997 Feb; 36(8):2291-9. PubMed ID: 9047331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the [Mg2+-(chromomycin A3)2]-d(TTGGCCAA)2 complex reveals GGCC binding specificity of the drug dimer chelated by a metal ion.
    Hou MH; Robinson H; Gao YG; Wang AH
    Nucleic Acids Res; 2004; 32(7):2214-22. PubMed ID: 15107489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of chromomycin A3 and mithramycin with the sequence d(TAGCTAGCTA)2.
    Chakrabarti S; Dasgupta D
    Indian J Biochem Biophys; 2001; 38(1-2):64-70. PubMed ID: 11563333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of triethylene glycol to mimic oligosaccharides: design and synthesis of a ligand based on chromomycin A3.
    Silva DJ; Kraml CM; Kahne D
    Bioorg Med Chem; 1994 Nov; 2(11):1251-9. PubMed ID: 7757421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of magnesium ion in the interaction between chromomycin A3 and DNA: binding of chromomycin A3-Mg2+ complexes with DNA.
    Aich P; Sen R; Dasgupta D
    Biochemistry; 1992 Mar; 31(11):2988-97. PubMed ID: 1550824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of simultaneous binding of Chromomycin A
    Murase H; Noguchi T; Sasaki S
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1832-1835. PubMed ID: 29657103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Mg2+ in the interaction of anticancer antibiotic, chromomycin A3 with DNA: does neutral antibiotic bind DNA in absence of the metal ion?
    Chakrabarti S; Aich P; Sarker D; Bhattacharyya D; Dasgupta D
    J Biomol Struct Dyn; 2000 Oct; 18(2):209-18. PubMed ID: 11089642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the anticancer antibiotic chromomycin A(3) with the nucleosome: role of core histone tail domains in the binding process.
    Mir MA; Dasgupta D
    Biochemistry; 2001 Sep; 40(38):11578-85. PubMed ID: 11560508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique binding cavity for divalent cations in the DNA-metal-chromomycin A3 complex.
    Itzhaki L; Weinberger S; Livnah N; Berman E
    Biopolymers; 1990 Feb; 29(3):481-9. PubMed ID: 2110008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The solution conformation of the antibiotic anticancer chromomycin A3 by two-dimensional NMR spectroscopy.
    Berman E; Kam M
    Prog Clin Biol Res; 1989; 289():217-27. PubMed ID: 2498896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of sequence-specific DNA binding, DNA cleavage, and topoisomerase I inhibition by the dimeric chromomycin A3 complexed with Fe(II).
    Hou MH; Lu WJ; Lin HY; Yuann JM
    Biochemistry; 2008 May; 47(20):5493-502. PubMed ID: 18426223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA structural similarity in the 2:1 complexes of the antitumor drugs trabectedin (Yondelis) and chromomycin A3 with an oligonucleotide sequence containing two adjacent TGG binding sites on opposing strands.
    Marco E; Gago F
    Mol Pharmacol; 2005 Dec; 68(6):1559-67. PubMed ID: 16150929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of the novel antitumor drug UCH9 complexed with d(TTGGCCAA)2 as determined by NMR.
    Katahira R; Katahira M; Yamashita Y; Ogawa H; Kyogoku Y; Yoshida M
    Nucleic Acids Res; 1998 Feb; 26(3):744-55. PubMed ID: 9443966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential interactions of antitumor antibiotics chromomycin A(3) and mithramycin with d(TATGCATA)(2) in presence of Mg(2+).
    Chakrabarti S; Mir MA; Dasgupta D
    Biopolymers; 2001; 62(3):131-40. PubMed ID: 11343281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The three-dimensional structure of the 4:1 mithramycin:d(ACCCGGGT)(2) complex: evidence for an interaction between the E saccharides.
    Keniry MA; Owen EA; Shafer RH
    Biopolymers; 2000 Aug; 54(2):104-14. PubMed ID: 10861371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between antitumor antibiotic chromomycin A3 and Mg2+. I. Evidence for the formation of two types of chromomycin A3-Mg2+ complexes.
    Aich P; Sen R; Dasgupta D
    Chem Biol Interact; 1992 Jun; 83(1):23-33. PubMed ID: 1643666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR investigation of mithramycin A binding to d(ATGCAT)2: a comparative study with chromomycin A3.
    Banville DL; Keniry MA; Shafer RH
    Biochemistry; 1990 Oct; 29(39):9294-304. PubMed ID: 2148686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crucial role of divalent metal ions in the DNA-acting efficacy and inhibition of the transcription of dimeric chromomycin A3.
    Hsu CW; Chuang SM; Wu WL; Hou MH
    PLoS One; 2012; 7(9):e43792. PubMed ID: 22984445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.